NEW YORK (Reuters Health) – After about a year, patients with early aggressive rheumatoid arthritis have the same improvement in disease activity whether treated initially with methotrexate plus…
NEW YORK (Reuters Health) – The sedative effects of benzodiazepine exposure through breast milk appear to present minimal risk of central nervous system (CNS) depression in infants, results…
NEW YORK (Reuters Health) – A systematic review and meta-analysis provides “reasonable” support for the current practice of giving adjuvant therapy to patients with resected biliary tract cancer…
NEW YORK (Reuters Health) – Paracervical block is effective in decreasing pain associated with first-trimester surgical abortion, suggest results of a randomized controlled trial conducted in Portland, Oregon.…
NEW YORK (Reuters Health) – The clinical spectrum of intracranial hemorrhage was similar in patients treated with warfarin or dabigatran in the pivotal RE-LY trial, a new analysis…
NEW YORK (Reuters Health) – In locally advanced or metastatic prostate cancer, intermittent androgen deprivation (IAD) is a “feasible, efficient and safe” alternative to continuous androgen deprivation (CAD)…
NEW YORK (Reuters Health) – Patients having coronary artery bypass grafting (CABG) have fewer postoperative heart rhythm complications and recover faster if they are pretreated with a statin,…
NEW YORK (Reuters Health) – When testing indicates fetal lung immaturity at 34 weeks’ gestation or more, administration of antenatal corticosteroids does not reduce respiratory problems in the…
NEW YORK (Reuters Health) – In the setting of primary percutaneous coronary intervention for ST segment-elevated MI, use of drug-eluting stents (DES) rather bare metal stents (BMS) is…
NEW YORK (Reuters Health) – Progression-free survival (PFS) is significantly longer in women with recurrent ovarian cancer when bevacizumab is added to chemotherapy, a multicenter team reports in…
NEW YORK (Reuters Health) – A combined oral contraceptive containing nomegestrol acetate and 17beta-estradiol (E2) taken in a 24–4-day regimen is somewhat more effective in preventing pregnancy than…
NEW YORK (Reuters Health) – Patients with NYHA class II heart failure are less likely to develop atrial fibrillation or flutter when given eplerenone, according to findings appearing…
